Education
About Us
Working with TipRanks
Follow Us
Sagimet Biosciences, Inc. Class A (SGMT)
NASDAQ:SGMT
Total Valuation
Sagimet Biosciences, Inc. Class A has a market cap or net worth of $227.55M. The enterprise value is $120.07M.
Market Cap$227.55M
Enterprise Value$120.07M
Share Statistics
Sagimet Biosciences, Inc. Class A has 31,001,108 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding31,001,108
Owned by Insiders10.15%
Owned by Institutions23.92%
Financial Efficiency
Sagimet Biosciences, Inc. Class A’s return on equity (ROE) is -0.29 and return on invested capital (ROIC) is -34.92%.
Return on Equity (ROE)-0.29
Return on Assets (ROA)-0.28
Return on Invested Capital (ROIC)-34.92%
Return on Capital Employed (ROCE)-0.35
Revenue Per Employee0.00
Profits Per Employee-3.25M
Employee Count14
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Sagimet Biosciences, Inc. Class A is ―. Sagimet Biosciences, Inc. Class A’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value0.91
Price to FCF―
Price to Operating Cash Flow-5.26
PEG Ratio―
Income Statement
In the last 12 months, Sagimet Biosciences, Inc. Class A had revenue of 0.00 and earned -45.57M in profits. Earnings per share was -1.45.
Revenue0.00
Gross Profit0.00
Operating Income-54.45M
Pretax Income-45.57M
Net Income-45.57M
EBITDA-45.57M
Earnings Per Share (EPS)-1.45
Cash Flow
In the last 12 months, operating cash flow was -54.23M and capital expenditures 0.00, giving a free cash flow of -54.23M billion.
Operating Cash Flow-54.23M
Free Cash Flow-54.23M
Free Cash Flow per Share-1.75
Dividends & Yields
Sagimet Biosciences, Inc. Class A pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta3.35
52-Week Price Change164.98%
50-Day Moving Average7.92
200-Day Moving Average5.49
Relative Strength Index (RSI)52.61
Average Volume (3m)570.70K
Important Dates
Sagimet Biosciences, Inc. Class A upcoming earnings date is Nov 12, 2025, After Close (Confirmed).
Last Earnings DateAug 13, 2025
Next Earnings DateNov 12, 2025
Ex-Dividend Date―
Financial Position
Sagimet Biosciences, Inc. Class A as a current ratio of 34.30, with Debt / Equity ratio of 0.12%
Current Ratio34.30
Quick Ratio34.30
Debt to Market Cap<0.01
Net Debt to EBITDA1.66
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Sagimet Biosciences, Inc. Class A has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Sagimet Biosciences, Inc. Class A EV to EBITDA ratio is -1.43, with an EV/FCF ratio of -1.54.
EV to Sales0.00
EV to EBITDA-1.43
EV to Free Cash Flow-1.54
EV to Operating Cash Flow-1.54
Balance Sheet
Sagimet Biosciences, Inc. Class A has $125.41M in cash and marketable securities with $152.00K in debt, giving a net cash position of $125.25M billion.
Cash & Marketable Securities$125.41M
Total Debt$152.00K
Net Cash$125.25M
Net Cash Per Share$4.04
Tangible Book Value Per Share$4.97
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Sagimet Biosciences, Inc. Class A is $27.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$27.00
Price Target Upside267.85% Upside
Analyst ConsensusStrong Buy
Analyst Count7
Revenue Growth Forecast-100.00%
EPS Growth Forecast-62.44%